Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) › Cash & EquivalentsCordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2020: $2942021: $99.7K2022: $6.6K2023: $23.1K2024: $37.3K2025: $3.2K$3.2K2020Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$3.2K-91.4%2024$37.3K+61.4%2023$23.1K+248.6%2022$6.6K-93.4%2021$99.7K+33806.1%2020$294—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share